Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Ragu

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature Reviews. Immunology|December 24, 2011
The bone marrow at the crossroads of blood and immunityFrancois E Mercier, Christine Ragu, David T Scadden
Blood|August 17, 2010
The transcription factor Srf regulates hematopoietic stem cell adhesionChristine Ragu, Gaelle Elain, Elena Mylonas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2015
Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CTLinda Jorgov, Françoise Montravers, Sona Balogova, et al.
Hemasphere|March 20, 2019
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 StudyElodie Gouache, Victoria Greze, Marion Strullu, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Haematologica|November 8, 2011
Functional analysis of the NUP98-CCDC28A fusion proteinArnaud Petit, Christine Ragu, Gwendoline Soler, et al.
Journal of Pediatric Hematology/Oncology|December 1, 2017
Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02Arthur Felix, Thierry Leblanc, Arnaud Petit, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Hemasphere|November 15, 2019
Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized TrialArnaud Petit, Stéphane Ducassou, Thierry Leblanc, et al.
Blood|July 19, 2011
Differential niche and Wnt requirements during acute myeloid leukemia progressionSteven W Lane, Yingzi J Wang, Cristina Lo Celso, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Reviews. Immunology|December 24, 2011
The bone marrow at the crossroads of blood and immunityFrancois E Mercier, Christine Ragu, David T Scadden
Blood|August 17, 2010
The transcription factor Srf regulates hematopoietic stem cell adhesionChristine Ragu, Gaelle Elain, Elena Mylonas, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 15, 2015
Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CTLinda Jorgov, Françoise Montravers, Sona Balogova, et al.
Hemasphere|March 20, 2019
Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 StudyElodie Gouache, Victoria Greze, Marion Strullu, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Haematologica|November 8, 2011
Functional analysis of the NUP98-CCDC28A fusion proteinArnaud Petit, Christine Ragu, Gwendoline Soler, et al.
Journal of Pediatric Hematology/Oncology|December 1, 2017
Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02Arthur Felix, Thierry Leblanc, Arnaud Petit, et al.
The Journal of Clinical Investigation|December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signalingKatrin Faber, Lars Bullinger, Christine Ragu, et al.
Hemasphere|November 15, 2019
Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized TrialArnaud Petit, Stéphane Ducassou, Thierry Leblanc, et al.
Blood|July 19, 2011
Differential niche and Wnt requirements during acute myeloid leukemia progressionSteven W Lane, Yingzi J Wang, Cristina Lo Celso, et al.
Pageof 2